SCHEMBL23630715

SCHEMBL23630715

O=C(Oc1cccc(OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(OC(=O)c4cc(O)c(O)c(OC(=O)c5cc(O)c(O)c(OC(=O)c6cc(O)c(O)c(O)c6)c5)c4)c3)c2)c1)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(OC(=O)c4cc(O)c(O)c(OC(=O)c5cc(O)c(O)c(O)c5)c4)c3)c2)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NSD2 O96028 1/20 0.70
SERPINE1 P05121 3/20 0.67
POLB P06746 3/20 0.65
POLA1 P09884 1/20 0.65
ANTXR2 P58335 1/20 0.65
MAPT P10636 1/20 0.49
SELL P14151 1/20 0.47
SELP P16109 1/20 0.47
L3MBTL1 Q9Y468 2/20 0.46
KDM4E B2RXH2 1/20 0.46
LMNA P02545 1/20 0.46
GAA P10253 1/20 0.46
NFKB1 P19838 1/20 0.46
XDH P47989 1/20 0.46
GFER P55789 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
FUT7 Q11130 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
ALDH1A1 P00352 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23630707 1.00 NSD2 (0.70) NSD2SERPINE1POLBPOLA1ANTXR2
SCHEMBL3004439 0.93 NSD2 (0.79) NSD2SERPINE1POLBPOLA1ANTXR2
SCHEMBL24265916 0.90 NSD2 (0.87) NSD2SERPINE1POLBPOLA1ANTXR2
SCHEMBL23630692 0.90 NSD2 (0.87) NSD2SERPINE1POLBPOLA1ANTXR2
SCHEMBL23630687 0.90 NSD2 (0.87) NSD2SERPINE1POLBPOLA1ANTXR2
SCHEMBL23630691 0.90 POLB (0.73) NSD2SERPINE1POLBPOLA1ANTXR2
SCHEMBL26402027 0.90 POLB (0.73) NSD2SERPINE1POLBPOLA1ANTXR2
SCHEMBL23630724 0.90 POLB (0.73) NSD2SERPINE1POLBPOLA1ANTXR2
SCHEMBL30257503 0.87 NSD2 (0.71) NSD2SERPINE1POLBPOLA1ANTXR2
SCHEMBL30257698 0.85 NSD2 (0.78) NSD2SERPINE1POLBPOLA1ANTXR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11779561-B2 Compounds and pharmaceutical uses thereof SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) 2023-10-10 US disclosed
US-20210214385-A1 INHIBITORS OF D-AMINO ACID OXIDASE AND USES THEREOF SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) 2021-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210214385-A1 INHIBITORS OF D-AMINO ACID OXIDASE AND USES THEREOF DAO, DDO, DDC NSD2 4322/4885SERPINE1 1124/4885POLB 1656/4885
US-11779561-B2 Compounds and pharmaceutical uses thereof ACE, ACE2, FURIN NSD2 2575/4885SERPINE1 318/4885POLB 2146/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.